We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Exagen

News List

Exagen, GSK Partner to Raise Lupus Diagnosis, Management Awareness americanpharmaceuticalreview
November 26, 2020
Exagen has extended its collaboration agreement with GlaxoSmithKline (GSK) to raise awareness of the importance of timely diagnosis of systemic lupus erythematosus (SLE), the most common and severe form of lupus.
Exagen to Evaluate Emergence of Autoimmune Diseases After COVID-19 Infection americanpharmaceuticalreview
November 11, 2020
Exagen announced a new study in collaboration with Brigham and Women’s Hospital in Boston, MA. This study will evaluate the incidence and risk factors for onset of rheumatic autoimmune diseases in people who recovered from COVID-19.
Exagen Partners with Sonora Quest to Offer AVISE Testing for Autoimmune Disease americanpharmaceuticalreview
March 17, 2020
Exagen has entered into a strategic partnership with Sonora Quest. The agreement provides preferred access through Sonora Quest in Arizona to Exagen’s AVISE testing.
Exagen collaborates with GSK for lupus treatment biospectrumasia
January 30, 2018
Both Exagen and GSK share a common goal to help SLE patients shorten the time to their diagnosis, which is nearly six years on average, and to facilitate improved patient health outcomes.